ASO Author Reflections: Implementing a Program of Talimogene laherparepvec
ASO Author Reflections
- 31 Downloads
Frances Collichio does research at the University of North Carolina that is supported by Amgen, Novartis and Merck.
- 6.Iafolla MA, Selby H, Warner K, et al. Rational design and identification of immune-oncology drug combinations. Ejcancer. 2018;2:38–57.Google Scholar
- 7.Ribas A, Dummer R, Puzano I, et al. Oncolytic virotherapy promotes intratumoral T cell infiltration and improves anti-PD-1 immunotherapy. Cell. 170(6):1109–19.e10. https://doi.org/10.1016/j.cell.2017.08.027.
- 8.National Cancer Institute. Clinical Trials Information. https://www.cancer.gov/about-cancer/treatment/clinical-trials/search. Accessed 8 Oct 2018.
© Society of Surgical Oncology 2018